中农联合(003042) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 reached ¥369,242,131.99, representing a 21.00% increase compared to the same period last year[2] - Net profit attributable to shareholders was ¥23,951,925.77, a significant increase of 402.19% year-on-year[2] - The basic earnings per share (EPS) for the period was ¥0.22, reflecting a 266.67% increase compared to the previous year[2] - The company's total revenue for Q3 2021 was 49,172,749.15, a decrease of 48.54% compared to the previous period due to a decline in product sales gross margin[7] - Net profit for Q3 2021 was 46,327,317.22, representing a 42.91% decrease from the previous year, primarily due to the decline in total profit[7] - The company's net profit for the third quarter of 2021 was CNY 46,327,317.22, down from CNY 81,144,297.59 in the same quarter of 2020, reflecting a decrease of approximately 42.8%[19] - The total comprehensive income for Q3 2021 was CNY 46,374,868.87, down from CNY 81,211,045.95 year-over-year[20] - Basic and diluted earnings per share for Q3 2021 were CNY 0.46, compared to CNY 0.99 in Q3 2020, reflecting a decline of 53.5%[20] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥3,009,318,933.62, marking a 30.81% increase from the end of the previous year[2] - The company's total liabilities as of September 30, 2021, were CNY 1,434,195,403.71, up from CNY 1,304,297,929.35 at the end of 2020, indicating an increase of about 9.93%[17] - Total assets reached CNY 3,009,318,933.62 as of September 30, 2021, compared to CNY 2,300,481,298.05 at the end of 2020, marking an increase of approximately 30.8%[17] - Total liabilities reached CNY 1,304,297,929.35, with current liabilities at CNY 1,132,371,147.38 and non-current liabilities at CNY 171,926,781.97[27] - Owner's equity totaled CNY 996,183,368.70, with retained earnings of CNY 536,111,965.95[28] Cash Flow - Cash flow from operating activities showed a negative net amount of ¥-86,760,326.50, indicating a decline of 148.90% year-to-date[2] - Operating cash inflow increased by 31.93% to 814,111,711.36, attributed to a higher cash collection ratio from sales[7] - Cash inflow from operating activities was CNY 814,111,711.36, an increase of 32% from CNY 617,074,366.44 in the previous year[22] - Cash outflow from operating activities totaled CNY 900,872,037.86, up from CNY 651,931,900.33, resulting in a net cash flow from operating activities of CNY -86,760,326.50[22] - Cash inflow from investment activities was CNY 410,070,260.00, significantly higher than CNY 24,859,288.00 in the previous year[23] - Cash outflow from investment activities reached CNY 801,484,500.46, compared to CNY 122,018,809.00 in the same period last year, leading to a net cash flow from investment activities of CNY -391,414,240.46[23] - Cash inflow from financing activities was CNY 1,049,698,181.25, a substantial increase from CNY 431,799,691.65 in the previous year[23] - The net increase in cash and cash equivalents for the period was CNY 47,046,943.78, compared to CNY 22,958,718.82 in the same period last year[23] - The ending balance of cash and cash equivalents was CNY 240,498,339.10, up from CNY 140,668,257.78 at the end of the previous year[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,395[9] - The largest shareholder, China Agricultural Production Materials Group, holds 30.57% of the shares, totaling 33,500,000 shares[10] - The shareholder voting rights delegation agreement signed on August 31, 2021, increased the voting rights held by China Agricultural Production Materials Group from 6.73% to 9.20%[12] - The company issued new shares, resulting in a 33.33% increase in share capital to 109,600,000.00[7] - Capital reserves increased by 152.17% to 841,742,975.63, driven by the premium from the initial public offering[7] Operational Highlights - The company has made progress on its project to produce 3,300 tons of pesticide raw materials, with trial production starting in July 2021[12] - The company is in the process of expanding its market presence and developing new products, as indicated by the ongoing construction of the bromopropyl project[12] - The company reported a decrease in research and development expenses to CNY 41,763,144.09 in Q3 2021 from CNY 47,165,463.43 in Q3 2020, a reduction of approximately 11.5%[19] Financial Adjustments - The adjustment for the new leasing standard resulted in a reduction of retained earnings by CNY 359,701.72[28] - The company recognized a right-of-use asset of CNY 3,324,022.46 and a corresponding lease liability of CNY 3,247,426.97 due to the new leasing standard[28] - The company reported a significant reduction in asset impairment losses by 80.86%, amounting to -1,848,304.40, due to rising product sales prices[7] - Financial expenses decreased by 41.36% to 14,000,590.41, due to reduced exchange losses and increased interest income[7] Audit Information - The company has not undergone an audit for the third-quarter report[29]